BRPI0810880A2 - novo composto de pirimidina com a estrutura de dibenzilamina e medicamento à base do mesmo - Google Patents

novo composto de pirimidina com a estrutura de dibenzilamina e medicamento à base do mesmo

Info

Publication number
BRPI0810880A2
BRPI0810880A2 BRPI0810880A BRPI0810880A BRPI0810880A2 BR PI0810880 A2 BRPI0810880 A2 BR PI0810880A2 BR PI0810880 A BRPI0810880 A BR PI0810880A BR PI0810880 A BRPI0810880 A BR PI0810880A BR PI0810880 A2 BRPI0810880 A2 BR PI0810880A2
Authority
BR
Brazil
Prior art keywords
pyrimidine compound
drug based
new pyrimidine
dibenzylamine structure
dibenzylamine
Prior art date
Application number
BRPI0810880A
Other languages
English (en)
Inventor
Ayumu Okuda
Haruki Shibata
Katsutoshi Miyosawa
Kimiyuki Shibuya
Koichi Yamazaki
Toru Miura
Tadaaki Ohgiya
Taro Aoki
Toshiharu Arai
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of BRPI0810880A2 publication Critical patent/BRPI0810880A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0810880A 2007-04-13 2008-04-10 novo composto de pirimidina com a estrutura de dibenzilamina e medicamento à base do mesmo BRPI0810880A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91162007P 2007-04-13 2007-04-13
PCT/JP2008/057058 WO2008129951A1 (ja) 2007-04-13 2008-04-10 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬

Publications (1)

Publication Number Publication Date
BRPI0810880A2 true BRPI0810880A2 (pt) 2016-07-19

Family

ID=39875479

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810880A BRPI0810880A2 (pt) 2007-04-13 2008-04-10 novo composto de pirimidina com a estrutura de dibenzilamina e medicamento à base do mesmo

Country Status (20)

Country Link
US (1) US7659271B2 (pt)
EP (1) EP2149563B9 (pt)
JP (2) JP5244095B2 (pt)
KR (1) KR101501299B1 (pt)
CN (1) CN101679309B (pt)
AU (1) AU2008241904B2 (pt)
BR (1) BRPI0810880A2 (pt)
CA (1) CA2683534C (pt)
DK (1) DK2149563T3 (pt)
EA (1) EA017321B1 (pt)
ES (1) ES2533910T3 (pt)
HK (1) HK1138274A1 (pt)
HU (1) HUE024898T2 (pt)
IL (1) IL201402A (pt)
MX (1) MX2009010962A (pt)
NZ (1) NZ580777A (pt)
PL (1) PL2149563T3 (pt)
PT (1) PT2149563E (pt)
TW (1) TWI439453B (pt)
WO (1) WO2008129951A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7750019B2 (en) 2006-08-11 2010-07-06 Kowa Company, Ltd. Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
US7790737B2 (en) * 2007-03-13 2010-09-07 Kowa Company, Ltd. Substituted pyrimidine compounds and their utility as CETP inhibitors
JP5319457B2 (ja) * 2008-08-25 2013-10-16 興和株式会社 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬
EP2332923A4 (en) * 2008-09-12 2012-08-01 Kowa Co PROCESS FOR THE PRODUCTION OF 5- [2- (METHYLTHIO) ETHOXY] AND PYRIMIDINE-2-AMINE
US8841478B2 (en) 2008-11-28 2014-09-23 Kowa Company, Ltd. Method for preparing trans-{4-[(alkylamino) methyl]- cyclohexyl}acetic acid ester
WO2012046681A1 (ja) 2010-10-04 2012-04-12 興和株式会社 脂質代謝関連ｍＲＮＡの発現抑制剤
ES2581557T3 (es) 2010-06-04 2016-09-06 Kowa Company, Ltd. Derivado de dibencilamina ópticamente activo y procedimiento de fabricación para el mismo
CN105837401A (zh) 2010-07-22 2016-08-10 兴和株式会社 光学活性1-溴-1-［3,5-双（三氟甲基）苯基］乙烷的制备方法
PL2729142T3 (pl) * 2011-07-08 2018-10-31 Novartis Ag Sposób leczenia miażdżycy tętnic u osobników z wysokim poziomem triglicerydów
US20140303198A1 (en) * 2011-11-29 2014-10-09 Kowa Company, Ltd. Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity
TW201335109A (zh) * 2011-12-02 2013-09-01 Kowa Co 光學活性化合物之製造方法
JP5555303B2 (ja) * 2011-12-02 2014-07-23 興和株式会社 光学活性ジベンジルアミン誘導体及びその製造方法
WO2013137371A1 (ja) * 2012-03-15 2013-09-19 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
WO2014017569A1 (ja) * 2012-07-26 2014-01-30 興和株式会社 血中ｌｄｌを低下させるための医薬
KR20160014620A (ko) 2013-05-31 2016-02-11 코와 가부시키가이샤 디벤질아민 구조를 갖는 피리미딘 화합물의 신규 형태
CN104628584B (zh) * 2013-11-08 2017-03-08 广州朗圣药业有限公司 一种适合工业化的高纯度达泊西汀的制备方法
CN106999491A (zh) * 2014-11-28 2017-08-01 兴和株式会社 医药
JP2019131472A (ja) * 2016-05-31 2019-08-08 興和株式会社 医薬組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
GT199900147A (es) 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147090A (en) 1998-09-17 2000-11-14 Pfizer Inc. 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
JP2003221376A (ja) 2001-11-21 2003-08-05 Japan Tobacco Inc Ｃｅｔｐ活性阻害剤
KR20040083493A (ko) 2002-02-01 2004-10-02 화이자 프로덕츠 인크. 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출형제약상 제형
KR100634195B1 (ko) 2002-08-30 2006-10-16 니뽄 다바코 산교 가부시키가이샤 디벤질아민 화합물 및 그 의약 용도
TWI345568B (en) 2004-04-02 2011-07-21 Mitsubishi Tanabe Pharma Corp Tetrahydronaphthyridine derivatives and a process for preparing the same
EP1737811B1 (en) * 2004-04-13 2016-08-10 Merck Sharp & Dohme Corp. Cetp inhibitors
EP1817297A1 (en) * 2004-11-23 2007-08-15 Pfizer Products Inc. Dibenzyl amine compounds and derivatives
EP1848430B1 (en) 2004-12-31 2017-08-02 Dr. Reddy's Laboratories Ltd. Novel benzylamine derivatives as cetp inhibitors
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
WO2006098394A1 (ja) 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
AU2006299557A1 (en) 2005-09-30 2007-04-12 Merck Sharp & Dohme Corp. Cholesteryl ester transfer protein inhibitors
CA2642130C (en) 2005-12-28 2013-04-02 Reddy Us Therapeutics, Inc. Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
KR20080086917A (ko) * 2005-12-29 2008-09-26 노파르티스 아게 콜레스테릴 에스테르 전달 단백질 (ｃｅｔｐ) 억제제로서의피리디닐 아민 유도체
PE20071025A1 (es) 2006-01-31 2007-10-17 Mitsubishi Tanabe Pharma Corp Compuesto amina trisustituido
UY30117A1 (es) 2006-01-31 2007-06-29 Tanabe Seiyaku Co Compuesto amina trisustituido
JP5225076B2 (ja) 2006-04-27 2013-07-03 田辺三菱製薬株式会社 チアゾール環を含むカルボン酸誘導体の医薬用途
AR060873A1 (es) * 2006-05-10 2008-07-16 Novartis Ag Derivados biciclicos como inhibidores de cetp
US7750019B2 (en) 2006-08-11 2010-07-06 Kowa Company, Ltd. Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
US7790737B2 (en) 2007-03-13 2010-09-07 Kowa Company, Ltd. Substituted pyrimidine compounds and their utility as CETP inhibitors

Also Published As

Publication number Publication date
CN101679309A (zh) 2010-03-24
NZ580777A (en) 2011-05-27
WO2008129951A1 (ja) 2008-10-30
ES2533910T3 (es) 2015-04-15
PL2149563T3 (pl) 2015-06-30
KR20100016332A (ko) 2010-02-12
DK2149563T3 (en) 2015-02-02
EP2149563A1 (en) 2010-02-03
JP2013129678A (ja) 2013-07-04
EP2149563B1 (en) 2015-01-07
PT2149563E (pt) 2015-02-18
IL201402A (en) 2015-10-29
TW200906804A (en) 2009-02-16
EP2149563B9 (en) 2015-04-22
US20090082352A1 (en) 2009-03-26
MX2009010962A (es) 2009-12-16
TWI439453B (zh) 2014-06-01
EA017321B1 (ru) 2012-11-30
CA2683534A1 (en) 2008-10-30
HK1138274A1 (en) 2010-08-20
JP5244095B2 (ja) 2013-07-24
CN101679309B (zh) 2012-02-29
EA200970943A1 (ru) 2010-04-30
CA2683534C (en) 2015-02-24
AU2008241904B2 (en) 2012-06-07
KR101501299B1 (ko) 2015-03-10
US7659271B2 (en) 2010-02-09
HUE024898T2 (en) 2016-02-29
EP2149563A4 (en) 2011-09-07
IL201402A0 (en) 2010-05-31
JPWO2008129951A1 (ja) 2010-07-22
AU2008241904A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
BRPI0810880A2 (pt) novo composto de pirimidina com a estrutura de dibenzilamina e medicamento à base do mesmo
BRPI0811549A2 (pt) Inibidor de carepa à base de polissacarídeos.
JP2006287195A5 (pt)
FR2888293B1 (fr) Palier a roulements tonneaux
ATE531957T1 (de) Lagerelement
BRPI0806587A2 (pt) Extendendo a vida útil de unidade rápida.
DK1858490T3 (da) Lægemiddelformer med forbedrede farmakokinetiske egenskaber
DE602007009735D1 (de) Schaukasten
FR2920898B1 (fr) Installation de gestion d'une base de donnees
BRPI0818562A2 (pt) Milho tolerante à seca com micotoxina reduzida
DE602006017825D1 (de) N konstruktion
IT1391427B1 (it) Compositi fotocatalitici a base di titanio e calcare.
BRPI0809002A2 (pt) Macrolídeos à base de eritromicina
DE602007002419D1 (de) Schaukasten
FR2920559B1 (fr) Base de donnees distribuee
FR2881395B1 (fr) Triporteur a balancier
JP2009047222A5 (pt)
FI7890U1 (fi) Tukielin
AT8219U3 (de) Schaukasten
ES1061864Y (es) Estructura soporte publicitaria.
FR2892105B1 (fr) Stockeur vertical a balancelles
ITMC20070081A1 (it) Preparazione mucolitica ed antitussigena a base di thymus vulgaris.
UA11155S (uk) Друковане видання
ITLT20060006U1 (it) Cuscinetto elastico base 60c28u-acmo
ATE536770T1 (de) Schaukasten

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 60/911,620 DE 13/04/2007, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E NO ART. 28 DO ATO NORMATIVO 128/1997, POR NAO ATENDER AO DISPOSTO NO ART. 27 DO ATO NORMATIVO 128/1997, POIS NAO FOI APRESENTADA CESSAO DA REFERIDA PRIORIDADE, QUE POSSUI DEPOSITANTE DIFERENTE DO DEPOSITANTE DA FASE NACIONAL.

B12F Other appeals [chapter 12.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]